Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07176416

Effective Phaco Time and Endothelial Cell Loss When Using Veritas

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cataract Eye Diseases Lens Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Aloha Vision Consultants

‘Aiea, Hawaii, 96701, United States

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients undergoing age-related cataract surgery.
  • Planned use of the Catalys Precision Laser System.
  • Planned implantation of TECNIS intraocular lenses (IOLs).

Exclusion criteria

  • Moderate-severe any disease state (deemed by the surgeon) that could increase risk of complicated cataract surgery (ie, pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, and prior refractive surgery).

Treatment and study plan

Veritas Vision System

Device

Veritas Vision System

Primary outcomes

  1. Effective phaco time per phacoemulsification procedure

    Time frame: Surgery (Day 0)

Secondary outcomes

  1. Endothelial cell loss

    Time frame: 1 monthspostoperatively

  2. Total case time

    Time frame: Surgery (Day 0)

    total case time per procedure

  3. Total phaco time

    Time frame: Surgery (Day 0)

    total phaco time per procedure

  4. Total volume used

    Time frame: Surgery (Day 0)

    Total volume used per procedure

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Aloha Vision Consultants

Other

Collaborators

  • Sengi

Registry information

Official study title

Assessment of Effective Phaco Time and Endothelial Cell Loss When Using a Novel Dual Mode Phacoemulsification System

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 16, 2025
Registry last updated
Oct 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.